Similar articles

• FURTHER OBSERVATIONS OF THE BINDING AND INHIBITION OF DIHYDROFOLIC REDUCTASE BY FOLIC ACID ANTAGONISTS.

  SCHRECKER AW, HUENNEKENS FM. SCHRECKER AW, et al. Biochem Pharmacol. 1964 May;13:731-42. doi: 10.1016/0006-2952(64)90009-7. Biochem Pharmacol. 1964. PMID: 14181276 No abstract available.
• Metabolism of folate antagonists.

  Johns DG, Valerino DM. Johns DG, et al. Ann N Y Acad Sci. 1971 Nov 30;186:378-86. doi: 10.1111/j.1749-6632.1971.tb31165.x. Ann N Y Acad Sci. 1971. PMID: 5289427 No abstract available.
• EFFECT OF FOLIC ACID AND ANALOGUES ON THE DEHYDROGENASE AND ISOMERASE ACTIVITIES OF LIVER ALCOHOL DEHYDROGENASE.

  SNYDER R, VOGEL W, SCHULMAN MP. SNYDER R, et al. J Biol Chem. 1965 Jan;240:471-4. J Biol Chem. 1965. PMID: 14253456 No abstract available.
• ENZYMATIC ASPECTS OF FOLIC ACID.

  FRIEDKIN M. FRIEDKIN M. Annu Rev Biochem. 1963;32:185-214. doi: 10.1146/annurev.bi.32.070163.001153. Annu Rev Biochem. 1963. PMID: 14144480 Review. No abstract available.
• Developmental delay in fetal aminopterin/methotrexate syndrome.

  Del Campo M, Kosaki K, Bennett FC, Jones KL. Del Campo M, et al. Teratology. 1999 Jul;60(1):10-2. doi: 10.1002/(SICI)1096-9926(199907)60:1<10::AID-TERA5>3.0.CO;2-H. Teratology. 1999. PMID: 10413333 Review.